Drug Profile
Cefetamet sodium
Alternative Names: cefetamet sodium salt; Sodium cefetametLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Hainan Eshun Pharmaceutical
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gram-negative infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Gram-negative-infections(In volunteers) in China (IV, Injection)
- 24 Apr 2013 Final adverse events and pharmacokinetic data from a phase I trial in Bacterial infection (in volunteers) presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT-2013)
- 09 Mar 2013 Phase-I clinical trials in Gram-negative infections in China (IV)